ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,059.00
1.86%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. AngioGenex Inc (CE) (AGGX)

  7. AngioGenex Inc (CE) (AGGX) Noticias

AGGX

AngioGenex (CE) (AGGX)

AngioGenex Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:AGGX
FechaHoraFuenteTítuloSímboloCompañía
17/02/202212:26Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:AGGXAngioGenex Inc (CE)
17/12/202114:41Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AGGXAngioGenex Inc (CE)
16/12/202105:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AGGXAngioGenex Inc (CE)
13/07/202014:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AGGXAngioGenex Inc (CE)
14/08/201916:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AGGXAngioGenex Inc (CE)
15/05/201916:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AGGXAngioGenex Inc (CE)
01/04/201911:59Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AGGXAngioGenex Inc (CE)
28/03/201915:50Edgar (US Regulatory)Annual Report (10-k)USOTC:AGGXAngioGenex Inc (CE)
04/02/201916:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AGGXAngioGenex Inc (CE)
29/09/201716:33Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (10-12g/a)USOTC:AGGXAngioGenex Inc (CE)
22/08/201716:00Edgar (US Regulatory)Securities Registration (section 12(g)) (10-12g)USOTC:AGGXAngioGenex Inc (CE)
22/08/201715:12Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:AGGXAngioGenex Inc (CE)
31/03/201014:45Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:AGGXAngioGenex Inc (CE)
08/01/201019:24Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:AGGXAngioGenex Inc (CE)
04/12/200915:38Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)USOTC:AGGXAngioGenex Inc (CE)
03/12/200905:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)USOTC:AGGXAngioGenex Inc (CE)
23/11/200916:21Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:AGGXAngioGenex Inc (CE)
16/11/200912:22Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:AGGXAngioGenex Inc (CE)
12/05/200915:16Edgar (US Regulatory)Current report filing (8-K)USOTC:AGGXAngioGenex Inc (CE)
14/04/200914:35Edgar (US Regulatory)Annual Report (10-K)USOTC:AGGXAngioGenex Inc (CE)
18/09/200814:01Edgar (US Regulatory)Angiogenex, Inc. - Initial Statement of Beneficial Ownership (3)USOTC:AGGXAngioGenex Inc (CE)
16/09/200811:52Edgar (US Regulatory)Angiogenex, Inc. - Statement of Changes in Beneficial Ownership (4)USOTC:AGGXAngioGenex Inc (CE)
14/08/200809:37Edgar (US Regulatory)Angiogenex, Inc. - Quarterly Report (10-Q)USOTC:AGGXAngioGenex Inc (CE)
25/07/200811:05Edgar (US Regulatory)Angiogenex, Inc. - Current report filing (8-K)USOTC:AGGXAngioGenex Inc (CE)
14/05/200812:31Edgar (US Regulatory)Angiogenex, Inc. - Quarterly Report of Financial Condition (10QSB)USOTC:AGGXAngioGenex Inc (CE)
02/04/200815:54Edgar (US Regulatory)Angiogenex, Inc. - Annual Report (Small Business Issuers) (10KSB)USOTC:AGGXAngioGenex Inc (CE)
31/03/200814:30Edgar (US Regulatory)Angiogenex, Inc. - Notification that Annual Report will be submitted late (NT 10-K)USOTC:AGGXAngioGenex Inc (CE)
14/02/200813:50Edgar (US Regulatory)Angiogenex, Inc. - Annual Statement of Changes in Beneficial Ownership (5)USOTC:AGGXAngioGenex Inc (CE)
14/02/200813:46Edgar (US Regulatory)Angiogenex, Inc. - Amended Statement of Beneficial Ownership (3/A)USOTC:AGGXAngioGenex Inc (CE)
19/11/200712:22Edgar (US Regulatory)Angiogenex, Inc. - Proxy Statement (definitive) (DEF 14A)USOTC:AGGXAngioGenex Inc (CE)
 Showing the most relevant articles for your search:USOTC:AGGX

Su Consulta Reciente

NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
OILBRENT
Brent Oil
NYSE
AXP
American Express
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados